Vaginal cancer incidence statistics

Coronavirus (COVID-19)

We have created a central resources hub for Health Professionals which hosts all of our CRUK resources and further materials to help with managing the pandemic. We are updating the information as guidance changes. There is also a page specifically for patients on our about cancer hub.

Health Professional COVID-19 and Cancer Hub

Cases

New cases of vaginal cancer, 2015-2017, UK

 

Proportion of all cases

Percentage vaginal cancer is of total cancer cases, 2015-2017, UK

 

Age

Peak rate of vaginal cancer cases, 2015-2017, UK

 

Trend over time

Vaginal cancer incidence rates have remained stable since the early 1990s, Females, UK

 

Vaginal cancer is not among the 20 most common cancers in females in the UK, accounting for less than 1% of all new cancer cases in females (2017).

In females and males combined, vaginal cancer is not among the 20 most common cancers in the UK, accounting for less than 1% of all new cancer cases (2017).[1-4]

Vaginal cancer incidence rates (European age-standardised (AS) rates Open a glossary item) are similar to the UK average in all the UK constituent countries.

Vaginal Cancer (C52), Number of New Cases, Crude and European Age-Standardised (AS) Incidence Rates per 100,000 Population, Females, UK, 2017

  England Scotland Wales Northern Ireland UK
Female Cases 207 27 7 6 247
Crude Rate 0.7 1.0 0.4 0.6 0.7
AS Rate 0.7 1.0 0.4 0.7 0.7
AS Rate - 95% LCL 0.6 0.6 0.1 0.1 0.7
AS Rate - 95% UCL 0.8 1.3 0.7 1.2 0.8
Persons Cases 207 27 7 6 247
Crude Rate 0.4 0.5 0.2 0.3 0.4
AS Rate 0.4 0.5 0.2 0.4 0.4
AS Rate - 95% LCL 0.3 0.3 0.1 0.1 0.3
AS Rate - 95% UCL 0.4 0.7 0.4 0.7 0.4

95% LCL and 95% UCL are the 95% lower and upper confidence limits Open a glossary item  around the AS Rate Open a glossary item

References

  1. Data were provided by the National Cancer Registration and Analysis Service (part of Public Health England), on request through the Office for Data Release, November 2019. Similar data can be found here: https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/cancerregistrationstatisticsengland/previousReleases
  2. Data were provided by ISD Scotland on request, April 2019. Similar data can be found here: http://www.isdscotland.org/Health-Topics/Cancer/Publications.
  3. Data were provided by the Welsh Cancer Intelligence and Surveillance Unit, Health Intelligence Division, Public Health Wales on request, December 2019. Similar data can be found here: http://www.wcisu.wales.nhs.uk.
  4. Data were provided by the Northern Ireland Cancer Registry on request, May 2019. Similar data can be found here: http://www.qub.ac.uk/research-centres/nicr/.

About this data

Data is for UK, 2017, ICD-10 C52.

Last reviewed:

Vaginal cancer incidence is strongly related to age, with the highest incidence rates being in older women. In the UK in 2015-2017, on average each year almost 4 in 10 new cases (38%) were in females aged 75 and over.[1-4]

Age-specific incidence rates rise steadily from around age 30-34 and more steeply from around age 50-54.The highest rates are in in the 90+ age group.

Vaginal cancer (C52), Average Number of New Cases per Year and Age-Specific Incidence Rates per 100,000 Females, UK, 2015-2017

For vaginal cancer, like most cancer types, incidence increases with age. This largely reflects cell DNA damage accumulating over time. Damage can result from biological processes or from exposure to risk factors. A drop or plateau in incidence in the oldest age groups often indicates reduced diagnostic activity perhaps due to general ill health.

References

  1. Data were provided by the National Cancer Registration and Analysis Service (part of Public Health England), on request through the Office for Data Release, November 2019. Similar data can be found here: https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/cancerregistrationstatisticsengland/previousReleases
  2. Data were provided by ISD Scotland on request, April 2019. Similar data can be found here: http://www.isdscotland.org/Health-Topics/Cancer/Publications.
  3. Data were provided by the Welsh Cancer Intelligence and Surveillance Unit, Health Intelligence Division, Public Health Wales on request, December 2019. Similar data can be found here: http://www.wcisu.wales.nhs.uk.
  4. Data were provided by the Northern Ireland Cancer Registry on request, May 2019. Similar data can be found here: http://www.qub.ac.uk/research-centres/nicr/.

About this data

Data is for UK, 2015-2017, C52.

Last reviewed:

Vaginal cancer European age-standardised (AS) incidence rates for females remained stable in the UK between 1993-1995 and 2015-2017.[1-4].

Over the last decade in the UK (between 2005-2007 and 2015-2017), vaginal cancer AS incidence rates for females remained stable.[1-4]

Vaginal Cancer (ICD-10 C52), European Age-Standardised Incidence Rates, Females, UK, 1993-2017

Vaginal cancer incidence rates have remained stable overall in all broad adult age groups in females in the UK since the early 1990s.[1-4] Rates in 0-24s have remained stable, in 25-49s have remained stable, in 50-59s have remained stable, in 60-69s have remained stable, in 70-79s have remained stable, and in 80+s have remained stable.

Vaginal Cancer (ICD-10 C52), European Age-Standardised Incidence Rates, By Age, Females, UK, 1993-2017

For vaginal cancer, like most cancer types, incidence trends largely reflect changing prevalence of risk factors and improvements in diagnosis and data recording. Recent incidence trends are influenced by risk factor prevalence in years past, and trends by age group reflect risk factor exposure in birth cohorts.

References

  1. Data were provided by the National Cancer Registration and Analysis Service (part of Public Health England), on request through the Office for Data Release, November 2019. Similar data can be found here: https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/cancerregistrationstatisticsengland/previousReleases
  2. Data were provided by ISD Scotland on request, April 2019. Similar data can be found here: http://www.isdscotland.org/Health-Topics/Cancer/Publications.
  3. Data were provided by the Welsh Cancer Intelligence and Surveillance Unit, Health Intelligence Division, Public Health Wales on request, December 2019. Similar data can be found here: http://www.wcisu.wales.nhs.uk.
  4. Data were provided by the Northern Ireland Cancer Registry on request, May 2019. Similar data can be found here: http://www.qub.ac.uk/research-centres/nicr/.

About this data

Data is for UK, 1993-2017, ICD-10 C52.

Last reviewed:

There is evidence for an association between vaginal cancer incidence and deprivation in England.[1] England-wide data for 2006-2010 show European age-standardised Open a glossary item incidence rates are 85% higher for females living in the most deprived areas compared with the least deprived.[1]

Vaginal Cancer (C52), European Age-Standardised Incidence Rates by Deprivation Quintile, Females, England, 2006-2010

The estimated deprivation gradient in vaginal cancer incidence between females living in the most and least deprived areas in England has not changed in the period 1996-2010.[1] It has been estimated that there would have been 50 fewer cancer cases each year in England during 2006-2010 if all females experienced the same incidence rates as the least deprived.[1]

References

  1. Cancer Research UK and National Cancer Intelligence Network. Cancer by deprivation in England: Incidence, 1996-2010, Mortality, 1997-2011. London: NCIN; 2014.

About this data

Data is for UK, 2006-2010, ICD-10 C52

Deprivation gradient statistics were calculated using incidence data for 2006-2010. The deprivation quintiles were calculated using the Income domain scores from the Index of Multiple Deprivation (IMD) from the following years: 2004, 2007 and 2010. Full details on the data and methodology can be found in the Cancer by Deprivation in England NCIN report.

Last reviewed:

Cancer stats explained

See information and explanations on terminology used for statistics and reporting of cancer, and the methods used to calculate some of our statistics.

Citation

You are welcome to reuse this Cancer Research UK content for your own work.
Credit us as authors by referencing Cancer Research UK as the primary source. Suggested styles are:

Web content: Cancer Research UK, full URL of the page, Accessed [month] [year].
Publications: Cancer Research UK ([year of publication]), Name of publication, Cancer Research UK.
Graphics (when reused unaltered): Credit: Cancer Research UK.
Graphics (when recreated with differences): Based on a graphic created by Cancer Research UK.

When Cancer Research UK material is used for commercial reasons, we encourage a donation to our life-saving research.
Send a cheque payable to Cancer Research UK to: Cancer Research UK, 2 Redman Place, London, E20 1JQ or

Donate online

We’re now on twitter.
Join the conversation and follow @CRUKHCPs for news, updates and opinion.

@CRUKHCPs

Acknowledgements

We are grateful to the many organisations across the UK which collect, analyse, and share the data which we use, and to the patients and public who consent for their data to be used. Find out more about the sources which are essential for our statistics.